CK LIFE SCIENCES INT'L., (HOLDINGS) INC.

Andere Sprachen CK Life Sciences Int'l., (Holdings) Inc.

Aktien

662762

KYG2176J1058

775

Markt geschlossen - Hong Kong S.E. Andere Börsenplätze 10:08:06 30.04.2024			% 5 Tage	% 1. Jan.
0,375 ^HKD	+2,74 %		+10,29 %	-39,52 %

05.04.	CK Life Sciences stellt präklinische Daten für zwei Krebsimpfstoffe vor; Aktien steigen um 11%	MT
19.03.	CK Life Sciences Int'l., (Holdings) Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

CK Life Sciences to Present Pre-Clinical Data for Two Cancer Vaccines; Shares Up 11%	05.04.
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19.03.
XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models Using AI and Biomarker Data	06.11.
CK Life Sciences to Present Preclinical Study of Cancer Vaccines at US Immunotherapy Conference	01.11.
Ck Life Sciences Int'l., Inc. Announces Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-Targeting Prame and PD-L1	01.11.
CK Life Sciences International's Profit Slumps 43% in H1; Shares Down 3%	16.08.23
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	01.08.23
CK Life Sciences Int'l., Inc. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payment Date 05 June 2023	14.03.23
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14.03.23
XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development opening a new paradigm for scientific innovation	28.11.22
XtalPi Inc. and CK Life Sciences to Collaborate in Ai-Empowered Tumour Vaccine Research and Development, Opening A New Paradigm for Scientific Innovation	25.11.22
CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Director and Change in Composition of the Remuneration Committee	01.09.22
CK Life Sciences' H1 Profit Down 35%	03.08.22
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	02.08.22
CK Life Sciences Investors Acquire Stake in Pharus for $5.5 Million Each	26.07.22
CK Life Sciences Int'l., Inc. Announces Ordinary Final Cash Dividend for the Year Ended 31 December 2021, Payable on 01 June 2022	15.03.22
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15.03.22
CK Life Sciences Int'l., Inc. acquired Gale Road vineyard.	15.03.22
CK Hutchison : CK Asset profits rise in H1	05.08.21
CK Life Sciences 'l : Posts Higher Profit, Revenue in H1	04.08.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen CK Life Sciences Int'l., (Holdings) Inc.

Aktien

662762

KYG2176J1058

775

Andere Sprachen

Filter